Surprisingly, alterations that were associated with a higher number of subclonal, but not clonal, events, included for the most part copy number changes (67%), especially in sarcomas, breast and ovarian cancers, and TP53 mutations, in lung adenocarcinoma, low grade glioma, and breast cancer (Fig 4C). This evidence concerns the gene TP53 and sarcoma.